NPS Pharmaceuticals Inc (NASDAQ:NPSP)
During the Trading Day
| 14.95 |  +0.42 / +2.89% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 15.14 | +0.19 / +1.27% |
Volume: 17.0K |
Latest NPSP News | Press Releases
| NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog May 14 / Zacks.com |
Today’s Trading
| Previous close | 14.53 |
| Today’s open | 15.08 |
| Day’s range | 14.60 - 16.37 |
| Volume | 7,459,530 |
| Average volume (3 months) | 2,048,132 |
| Market cap | $1.4B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +51.11% |
| Earnings growth (this year) | +7.20% |
| Earnings growth (next 5 years) | +80.00% |
| Revenue growth (last year) | +28.53% |
| P/E ratio | NM |
| Price/Sales | 6.06 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VVUSVIVUS Inc | +0.36 | +2.74% |
| ACORAcorda Therapeutics ... | -0.32 | -0.99% |
| AKRXAkorn Inc | -0.28 | -1.89% |
| SNTSSantarus Inc | -0.02 | -0.09% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $130.6M |
| Annual profit (last year) | -$18.7M |
| Net profit margin | -14.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Francois Nader, MD, MBA |
Chief Financial Officer & Executive Vice President Luke M. Beshar, CPA |
Corporate headquarters Bedminster, New Jersey |
Forecasts
